← Back to Search

Nighttime Feminine Product for Heavy Menstrual Bleeding

N/A

Waitlist Available

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial evaluates how menstrual products & sleep behaviors affect sleep during 3 menstrual cycles for women with heavy bleeding.

Who is the study for?

This trial is for women aged 18-50 with heavy menstrual bleeding who use pads at night and often wake up or take measures to prevent leakage. They must have regular menstrual cycles, an intact uterus, one ovary, and be generally healthy without significant diseases. Night-shift workers or those planning pregnancy are excluded.Check my eligibility

What is being tested?

The study tests how a standardized nighttime feminine product affects sleep during menstruation over three cycles. The first cycle is observed as a baseline; the second involves using the product, and the third adds behavioral changes to avoid leaks.See study design

What are the potential side effects?

There may not be direct side effects from using the nighttime feminine products themselves; however, participants might experience discomfort or disruption in their usual sleep patterns due to adherence to new behaviors required by the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Pittsburgh Sleep Quality Index (PSQI)

Trial Design

1Treatment groups

Experimental Treatment

Group I: Women with reported heavy mensesExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor

1,585 Previous Clinical Trials

917,206 Total Patients Enrolled

Media Library

Women with reported heavy menses Clinical Trial Eligibility Overview. Trial Name: NCT05722444 — N/A

Heavy Menstruation Research Study Groups: Women with reported heavy menses

Heavy Menstruation Clinical Trial 2023: Women with reported heavy menses Highlights & Side Effects. Trial Name: NCT05722444 — N/A

Women with reported heavy menses 2023 Treatment Timeline for Medical Study. Trial Name: NCT05722444 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial accept participants aged 50 and over?

"Prospective participants must meet the eligibility criteria, which mandates that they are between 18 and 50 years of age."

Answered by AI

Which demographic is eligible to participate in this research?

"Patients within the age range of 18-50 and suffering from heavy menstruation may be eligible to partake in this trial, which is aiming for a total of 100 recruits."

Answered by AI

What is the upper limit of individuals participating in this research?

"Affirmative. Per the details on clinicaltrials.gov, this examination is still in need of participants as it was initially posted on January 30th 2023 and recently revised February 1st 2023. The research aims to recruit a total of 100 patients from one medical site."

Answered by AI

Is enrollment for this research study still available?

"Reportedly, the clinical trial is presently recruiting participants. According to information hosted on clinicaltrials.gov, it was first posted on January 30th 2023 and last updated February 1st of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sleep and Health Outcomes in Women With Heavy Menses

Jessica Walter 2023. "Sleep and Health Outcomes in Women With Heavy Menses". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05722444.